Delivery Order SPE2DR25D1201-SPE2DR26FAJQF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,647.72 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on May 27, 2025, with a completion date of May 28, 2025. This competitive award, placed under a firm fixed-price contract, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units) with a ceiling value of $1,659.37. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,188.64 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $13,125.18 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed-price contract, which is a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. The award was made through open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $4,422.80. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,988.33 on June 2, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens with an ultimate completion date of June 3, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $45,827.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $18,956.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injectors (0.5 ml). The contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $32,161.80 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed-price contract with a completion deadline of September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,233.41 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on July 31, 2025, with completion scheduled for August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJQFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,768.60 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pens on October 28, 2025, with completion targeted for October 29, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Health Agency's pharmaceutical supply needs through AmerisourceBergen's comprehensive prime vendor agreement, which enables the company to supply a broad range of medications and medical supplies to military healthcare systems. Zepbound, a GLP-1 receptor agonist used for weight management, falls within the company's extensive portfolio of brand-name and specialty medications. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen fulfills pharmaceutical requirements across multiple therapeutic domains, making it a key supplier for military and veteran healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 10/28/25 |